4/23
09:00 am
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
4/23
08:52 am
cdtx
Rating for CDTX
Medium
Report
Rating for CDTX
4/8
03:09 pm
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.